Nutex Health (US:NUTX) GlobeNewswire News Roomยท2025-08-25 20:19Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for alleged misleading statements and fraudulent activities related to its third-party vendor HaloMD, which reportedly engaged in a scheme to defraud insurance companies [1][5]. Group 1: Events Leading to the Lawsuit - On July 22, 2025, Blue Orca Capital released a report claiming that HaloMD was involved in fraudulent activities, leading to a significant drop in Nutex's share price by approximately 10.05%, from $111.19 to $100.01 per share [3]. - On August 14, 2025, Nutex announced a delay in filing its quarterly report with the SEC due to accounting adjustments, resulting in a further decline in share price by about 16.39%, closing at $92.91 per share on August 15, 2025 [4]. Group 2: Allegations in the Lawsuit - The lawsuit alleges that Nutex made false or misleading statements regarding HaloMD's operations and the sustainability of its revenues [5]. - It is claimed that Nutex overstated its ability to remediate internal control weaknesses and improperly classified stock-based compensation obligations, increasing the risk of delayed financial reporting [5].